Now Live The BioInsights Podcast Modernizing cell therapy manufacturing to reduce vein-to-vein times

Listen now
Announcements

GPB Scientific announces go-to-market kickoff under new brand: Curate Biosciences

CARLSBAD, Calif., February 8, 2022 – GPB Scientific, Inc. has launched its go-to-market activities for the transformational Curate® Cell Processing System to streamline the manufacture of cell therapies, making them economically and reliably available to the largest number of patients. The company’s advanced cell separation platform is in evaluations at select biopharmas, contract manufacturers, and academic centers ahead of the system’s upcoming commercial introduction. Anticipating the commercial launch, the company is changing its name to “Curate Biosciences” to better communicate its benefits to the gene and cell therapy industry.

Read the full story.